SCHEMBL23631545

SCHEMBL23631545

CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@H](CF)[C@@H](F)[C@@H]1OC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.55
▸ LMNA P02545 3/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAG P20916 1/20 0.40
▸ MMP12 P39900 2/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ TP53 P04637 1/20 0.37
▸ MDM2 Q00987 1/20 0.37
▸ SSTR1 P30872 1/20 0.37
▸ SSTR2 P30874 1/20 0.37
▸ SSTR4 P31391 1/20 0.37
▸ SSTR3 P32745 1/20 0.37
▸ SSTR5 P35346 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23631539 0.92 POLB (0.55) POLBLMNAKMT2AL3MBTL1ALDH1A1
SCHEMBL23631561 0.90 POLB (0.66) POLBLMNAKMT2AL3MBTL1ALDH1A1
SCHEMBL23631562 0.85 POLB (0.51) POLBLMNAKMT2AL3MBTL1ALDH1A1
SCHEMBL21097453 0.82 POLB (0.79) POLBLMNAKMT2AL3MBTL1ALDH1A1
SCHEMBL8931476 0.82 POLB (0.79) POLBLMNAKMT2AL3MBTL1ALDH1A1
SCHEMBL24351978 0.82 POLB (0.56) POLBLMNAKMT2AL3MBTL1MAG
SCHEMBL8931470 0.82 POLB (0.79) POLBLMNAKMT2AL3MBTL1ALDH1A1
SCHEMBL5840906 0.82 POLB (0.49) POLBLMNAKMT2AL3MBTL1TP53
SCHEMBL5840913 0.82 POLB (0.49) POLBLMNAKMT2AL3MBTL1TP53
SCHEMBL23631546 0.82 L3MBTL1 (0.48) POLBLMNAKMT2AL3MBTL1MAG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365212-B2 Fluorinated N-acetyl glucosamine analogs and xylose derivatives UTI LIMITED PARTNERSHIP (CA) 2022-06-21 — — US disclosed
US-20210214384-A1 FLUORINATED N-ACETYL GLUCOSAMINE ANALOGS AND XYLOSE DERIVATIVES UTI LIMITED PARTNERSHIP (CA) 2021-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11365212-B2 Fluorinated N-acetyl glucosamine analogs and xylose derivatives FUT6, FUT5, B3GNT2 POLB 4645/4885LMNA 3434/4885KMT2A 2993/4885
US-20210214384-A1 FLUORINATED N-ACETYL GLUCOSAMINE ANALOGS AND XYLOSE DERIVATIVES FUT6, FUT5, B3GNT2 POLB 4645/4885LMNA 3434/4885KMT2A 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback